Lanean...
Improving risk‐stratification of natalizumab‐associated PML
Based on publicly available data, we reevaluated current algorithms for stratifying the risk of progressive multifocal leukoencephalopathy (PML) in natalizumab‐treated patients with multiple sclerosis, and found that there are a number of issues. First and foremost, our analysis highlights the neces...
Gorde:
| Argitaratua izan da: | Ann Clin Transl Neurol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7951098/ https://ncbi.nlm.nih.gov/pubmed/33539683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51130 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|